GEC-ESTRO 关于106Ru 眼科敷贴器治疗眼黑色素瘤实践的物理师调查
2022年BRAPHYQS与头颈及皮肤GEC-ESTRO工作组对106Ru眼科敷贴近距离治疗开展物理师问卷调查,共纳入65份物理师回复。多数中心未独立测量参考深度吸收剂量、百分深度剂量和离轴数据,约三分之一中心采用基于影像的治疗计划,边距和处方剂量变异大。
要点
- 多数中心未独立测量参考深度吸收剂量、百分深度剂量和离轴数据。
- 缺乏校准服务和合适设备是未独立测量的主要原因。
- 约三分之一中心采用基于影像的治疗计划,边距和处方剂量变异大。
核心结论
- 物理师调查显示106Ru源的质量控制和治疗计划实践存在广泛变异。
研究设计与样本
- 2022年BRAPHYQS与头颈及皮肤GEC-ESTRO工作组开展的问卷调查,包含物理师和医师两部分,本文报告物理师结果并纳入三个与医师问卷重叠的问题。
- 共纳入65份物理师回复。
主要发现
- 多数中心未独立测量参考深度吸收剂量、百分深度剂量和离轴数据,主要原因是缺乏校准服务和合适设备。
- 约三分之一中心表示采用基于影像的治疗计划。
- 尽管有指南可用,边距使用和处方剂量仍显示很大变异性。
- 许多受访者表达了对临床实践多方面改进的强烈愿望。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: 106Ru eye plaque brachytherapy (BT, interventional radiotherapy) is an eye-preserving treatment for uveal melanoma performed in about 100 clinics worldwide. Despite this relatively low number, there is a considerable variation in clinical practice. In 2022, the BRAPHYQS and Head & Neck and Skin GEC-ESTRO working groups conducted a survey to map the current clinical practice. The survey consisted of a physicist and a physician part. This paper describes the physicist results. However, three physician questions with overlapping interest are included here as well. MATERIALS AND METHODS: The survey questions pertained to commissioning and quality control (QC) of the plaques, treatment planning, radiobiological correction, as well as more general questions on practice improvement. The questions overlapping with the physician survey were related to dose prescription and margins. RESULTS: Sixty-five physicist responses were included. A majority of the centres do not perform an independent measurement of the absorbed dose at reference depth, percentage depth dose (PDD) and off-axis data. A lack of calibration services and suitable equipment are the main reasons. About one third of the centres indicated that they do image based treatment planning. The use of margins and dose prescription showed a large variability, despite the availability of guidelines [1]. Many respondents expressed a strong wish for improvement in a wide range of aspects of clinical practice. CONCLUSION: The physics survey showed a wide variability regarding quality control of the 106Ru sources and treatment planning practice.
引用
- De Brabandere M, Placidi E, Siebert FA, et al. GEC-ESTRO survey of 106Ru eye applicator practice for ocular melanoma - Physicist survey. Radiother Oncol. 2024. PMID: 38309583. doi:10.1016/j.radonc.2024.110114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。